Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy

BACKGROUND: Currently, precise predictors in gastric cancer patients undergoing neoadjuvant chemotherapy are lacking. The study aims to investigate the prognostic value of the monocyte to lymphocyte ratio (MLR) in patients with advanced gastric cancer receiving S-1 plus oxaliplatin (SOX) or oxalipla...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Hao, Ying, Zhu, Lihua, Li, Sen, Zuo, Yanjiao, Zhang, Yuxin, Song, Hongjiang, Xue, Yingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558583/
https://www.ncbi.nlm.nih.gov/pubmed/28860808
http://dx.doi.org/10.2147/OTT.S140118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558583/
https://www.ncbi.nlm.nih.gov/pubmed/28860808
http://dx.doi.org/10.2147/OTT.S140118

Ejemplares similares